Login / Signup
Tom Götze
ORCID
Publication Activity (10 Years)
Years Active: 2024-2024
Publications (10 Years): 4
Top Topics
Emergency Department
Poor Prognosis
Breast Cancer Cells
Endoplasmic Reticulum
Top Venues
ChemMedChem
RSC medicinal chemistry
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Aleksandr Kazimir
,
Tom Götze
,
Peter Lönnecke
,
Blagoje Murganic
,
Sanja Mijatovic
,
Danijela Maksimović-Ivanić
,
Evamarie Hey-Hawkins
Exploring Raloxifene-Based Metallodrugs: A Versatile Vector Combined with Platinum(II), Palladium(II) and Nickel(II) Dichlorides and Carborates against Triple-Negative Breast Cancer.
ChemMedChem
19 (14) (2024)
Aleksandr Kazimir
,
Tom Götze
,
Blagoje Murganic
,
Sanja Mijatovic
,
Danijela Maksimović-Ivanić
,
Evamarie Hey-Hawkins
Bipyraloxifene - a modified raloxifene vector against triple-negative breast cancer.
RSC medicinal chemistry
15 (6) (2024)
Aleksandr Kazimir
,
Tom Götze
,
Peter Lönnecke
,
Blagoje Murganic
,
Sanja Mijatovic
,
Danijela Maksimović-Ivanić
,
Evamarie Hey-Hawkins
Exploring Raloxifene-Based Metallodrugs: A Versatile Vector Combined with Platinum(II), Palladium(II) and Nickel(II) Dichlorides and Carborates against Triple-Negative Breast Cancer.
ChemMedChem
(2024)
Aleksandr Kazimir
,
Tom Götze
,
Blagoje Murganic
,
Sanja Mijatovic
,
Danijela Maksimović-Ivanić
,
Evamarie Hey-Hawkins
Bipyraloxifene - a modified raloxifene vector against triple-negative breast cancer.
RSC medicinal chemistry
15 (6) (2024)